Founded in 2005, Ceres Venture Fund focuses on investing in early stage ventures, particularly in the healthcare, information technology, and business sectors. Some of their portfolio companies include CS-Keys, a biotechnology company specializing in cancer biomarker discovery, and TrafficCast, a provider of real-time and predictive traffic information. Ceres Venture Fund has invested $6.3M in CS-Keys and $3.5M in TrafficCast, aiming to partner with entrepreneurs and provide them with the necessary resources for success in their early stages of growth.